British Journal of Anaesthesia, Vol 81, Issue 3 422-424, Copyright © 1998 by The Board of Management and Trustees of the British Journal of Anaesthesia
S. Dutta, Y. Matsumoto, A. Muramatsu, M. Matsumoto, M. Fukuoka and W. F. Ebling
Based on volume-flow relationships, CNS agents that are highly lipid
soluble (log octanol-water partition coefficient > 2) are expected to
have equilibration half-times (T1/2 kE0) that are proportional to brain
solubility. Propofol, the most lipophilic anaesthetic in clinical use, has
T1/2 kE0 values of 1.7 and 2.9 min in rats and humans, respectively,
compared with an expected value of at least 8 min. As a first step in
exploring this discrepancy between observed and predicted values, we
determined the steady state brain:plasma and brain:blood partition
coefficients in rats after a 4-h infusion of propofol. Brain:plasma and
brain:blood partition coefficients were 8.2 (SD 1.6) and 3.0 (0.5),
respectively. T1/2 kE0 predictions based on brain: blood partitioning in
rats are more in agreement with the observed equilibration half-time,
suggesting that drug bound to the formed elements of blood participates in
the uptake and transfer of propofol to its effect site.
LABORATORY INVESTIGATIONS
Steady-state propofol brain:plasma and brain:blood partition coefficients and the effect-site equilibration paradox
Department of Pharmaceutics, State University of New York at Buffalo, Amherst, NY 14260, USA; Department of Pharmaceutics and Department of Clinical Pharmacology and Toxicology, Showa College of Pharmaceutical Sciences, Machida, Tokyo, 194 Japan; Department of Pharmaceutics, Showa College of Pharmaceutical Sciences, Machida, Tokyo, 194 Japan; Department of Clinical Pharmacology and Toxicology, Showa College of Pharmaceutical Sciences, Machida, Tokyo, 194 Japan
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. Ravenelle, P. Vachon, A. E. Rigby-Jones, J. R. Sneyd, D. Le Garrec, S. Gori, D. Lessard, and D. C. Smith Anaesthetic effects of propofol polymeric micelle: a novel water soluble propofol formulation Br. J. Anaesth., August 1, 2008; 101(2): 186 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gredell, P. A. Turnquist, M. B. MacIver, and R. A. Pearce Determination of diffusion and partition coefficients of propofol in rat brain tissue: implications for studies of drug action in vitro Br. J. Anaesth., December 1, 2004; 93(6): 810 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bauerle, C.-A. Greim, M. Schroth, M. Geisselbrecht, A. Kobler, and N. Roewer Prediction of depth of sedation and anaesthesia by the NarcotrendTM EEG monitor Br. J. Anaesth., June 1, 2004; 92(6): 841 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Ya Deau, C. M. Morelli, and S. Desravines Inhibition by Propofol of Intracellular Calcium Mobilization in Cultured Mouse Pituitary Cells Anesth. Analg., November 1, 2003; 97(5): 1325 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Dawidowicz, A. Fijalkowska, A. Nestorowicz, R. Kalitynski, and T. Trojanowski Cerebrospinal fluid and blood propofol concentration during total intravenous anaesthesia for neurosurgery Br. J. Anaesth., January 1, 2003; 90(1): 84 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Dawidowicz, R. Kalitynski, A. Nestorowicz, and A. Fijalkowska Changes of Propofol Concentration in Cerebrospinal Fluid During Continuous Infusion Anesth. Analg., November 1, 2002; 95(5): 1282 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Filippi, A. M. Ulug, D. Lin, L. A. Heier, and R. D. Zimmerman Hyperintense Signal Abnormality in Subarachnoid Spaces and Basal Cisterns on MR Images of Children Anesthetized with Propofol: New Fluid-attenuated Inversion Recovery Finding AJNR Am. J. Neuroradiol., February 1, 2001; 22(2): 394 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Valle, M. J. Garrido, J. M. Pavón, R. Calvo, and I. F. Trocóniz Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effects of Main Active Metabolites of Tramadol, (+)-O-Desmethyltramadol and (-)-O-Desmethyltramadol, in Rats J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 646 - 653. [Abstract] [Full Text] |
||||



